Symposia and Workshops 

 Are you speaking at the Annual Meeting? >>

Check out these exciting sessions to be presented at the 2011 Annual Meeting. Information about learning objectives and speakers will be available soon. Symposia The Applications of Molecular and Functional Imaging as Biomarkers for Targeted Therapies in Early Clinical Drug Development Assessing the Effect of Impaired Kidney Function on Drug Exposure/ Response, and Dosing: Challenges and Opportunities

 Clinical Trial Design in the Era of Targeted Therapy and Personalized Medicine in Oncology

 Drug Development for the Treatment of Pediatric Cancers

 Drug Dosing in Patients with Hepatic Impairment

 Extending Pharmacometrics to Strategic Decisions

 Risk Management During Clinical Drug Development

 The Roadmap to Success of Personalized Drug Therapy

 Translational Bioinformatics—The Next Frontier for Clinical Pharmacology

 Vaccines – Global Challenges, Global Opportunities
 Joint Symposium with the Canadian Society for Pharmacology and Therapeutics.

 Workshops

 Antigen-sink Effect: Mechanism, Characterization and Implications in mAb Development

 Applications of Systems Biology in Drug Development, Drug Safety and Decision-Making

 Epigenetics in the Treatment of Cancer: State of the Science and Future Directions

 Hedgehog Signaling: Tales of Cyclops, Stem Cells, and a Potential New Paradigm in Targeted Cancer Therapy

 How to Rationally Dose Opioids in Populations At Risk for Opioid Related Morbidity—Breast Feeding Infants,  
 Children, and Difficult Adults

 Rare Disease Initiatives at NIH and FDA

 Regulatory Guidance on Drug-Drug Interactions: Comparing Draft Guideline/Guidance Documents by EMA and
 FDA

 Use of Informative Drop-Out Models in Decision Making to Enhance Evaluation of Efficacy and/or Dose   
 Response